Home › Acute Pain › NCT04849455

Erector Spinae Plane Block Catheters and Intrathecal Morphine for Hepatic Resection

Erector Spinae Plane Block Catheters: The Role in Acute Postoperative Pain After Hepatic Resection With Intrathecal Morphine

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* undergoing hepatic resection
* Admitting service requests APS consult
* \>18 years old and able to provide consent

Exclusion criteria:

* pregnancy
* incarceration
* inability to communicate with the investigators and hospital staff
* severe hepatic disease
* chronic high-dose opioid use (defined as daily use for more than 4 weeks prior to surgery of at least the equivalent of 20 mg oxycodone);
* BMI \> 40 kg/m2
* allergy to study medications (lidocaine, ropivacaine)

About the study

To determine whether the addition of erector spinae plane (ESP) catheters to existing multimodal analgesic regimen with intrathecal morphine provides superior postoperative analgesia in patients undergoing hepatic resection compared with patients not receiving ESP catheters.

What is being tested

• 0.2% ropivacaine local anesthetic continuous erector spinae plane block (drug)
• 0.2% ropivacaine local anesthetic superficially taped continuous erector spinae plane block (drug)
• Spinal Morphine (drug)

Sponsor: University of California, San Diego · Participants: 70 · Started: May 24, 2021

Contact the study team

• Engy T Said, MD · Phone: 5597371904

Official record on ClinicalTrials.gov — NCT04849455

Locations in the U.S.

Conditions

• Acute Pain
• Pain After Surgery

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.